Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
US5631283A · kind A · utility
4Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1994 |
| Grant date | May 20, 1997 |
| Priority date | — |
| Expiry date | Feb 2, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of sialidase inhibitors or sialic acid is useful as me for treating inflammatory conditions and for intervening in infectious processes in instances where pathogenicity of the disease-causing organism is increased by microbial surface interaction with host cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.